Budget allocation to Ministry of Ayush to go up 7.6% in FY26
|
Gireesh Babu, New Delhi
February 05 , 2025
|
|
The Union Budget 2025-26 proposes to allocate around Rs. 3,993 crore for the Ministry of Ayush, around 7.6 per cent higher than the Rs. 3,712.5 crore Budget Estimates (BE) for the fiscal 2024-25. The allocation is almost 14.2 per cent more compared to the Revised Estimates (RE) of Rs. 3,497.6 crore for the fiscal year 2024-25.
According to the Demands for Grants for the Ministry for the fiscal 2025-26, RE for the current fiscal is almost 5.8 per cent lower compared to the budget allocation in the beginning of the fiscal year, owing to the lower allocation including for the Central Sector Schemes including Ayurgyan, Ayurswasthay Yojana, and Ayush Oushadhi Gunvatta evum Uttapadan Samvardhan Yojana (AOGUSY).
Ayurgyan, the scheme implemented by the Ministry with the aim to promote Ayush education, research and innovation through academic activities, training, capacity building etc., has seen the BE of Rs. 49.5 crore for FY 25 reduced by 45.5 per cent to Rs. 27 crore in the RE stage. For FY26, in the latest Budget, the allocation has been increased to Rs. 50 crore, close to the BE of the previous fiscal.
For Ayurswasthay Yojana, an umbrella scheme containing of previous scheme of Ministry of Ayush namely Ayush and Public Health Initiatives (PHI) and Centre of excellence (CoE), the BE for the fiscal year 2025-26 is Rs. 62.6 crore, almost 13.8 per cent lower compared to the Rs. 72.59 crore BE during the fiscal year 2024-25. At RE stage, the budget estimate has been reduced to Rs. 29 crore, for FY 2024-25.
For the AOGUSY scheme for augmenting safety and quality of Ayush drugs, the latest budget proposes allocation of Rs. 27 crore, which is slightly up from the Rs. 25 crore in the BE stage for the current fiscal year. However, in the RE stage, the allocation for the current fiscal has been estimated to decline to Rs. 15 crore.
However, for the Central Sector Scheme for Conservation, Development and Sustainable Management of Medicinal Plants, the allocation for FY26 is expected to growth to Rs. 65 crore, almost 31 per cent up from Rs. 49.49 crore in the BE stage for FY25. The Scheme has seen the allocation declining to Rs. 40 crore in the RE stage in FY25.
The Budget allocation for statutory and regulatory bodies including the National Commission for Indian System of Medicine (NCISM) and National Commission for Homoeopathy (NCH) reports an increase of 11.6 per cent to Rs. 219.20 crore for FY 26, as compared to Rs. 196.48 crore in the BE stage of FY25.
For the autonomous bodies including the Central Councils of Research in Ayurvedic Sciences, Homoeopathy, Unani Medicine, among others, apart from the All Indian Institute of Ayurveda (AIIA) and the National Institute of Homoeopathy (NIH), Kolkata, the budget allocation for FY26 has seen an increase of 6.35 per cent to Rs. 1,965.80 crore, as compared to Rs. 1,848.40 crore in the BE stage of FY25.
Interestingly, in the RE stage of the current fiscal, the expenditure has been reported to exceed the BE, to reach Rs. 1,887.83 crore.
Allocation for the Pharmacopoeia Commission for Indian Medicine and Homoeopathy (PCIM&H) for FY26 has been proposed to go up to Rs. 21.96 crore, from Rs. 20.80 crore in the BE stage of FY25. There was an increase in the capital expenditure for the Commission during the current fiscal, reporting the allocation in the RE stage growing to Rs. 22.21 crore.
The expenditure for the Secretariat of the Ministry is expected go see a significant growth in the upcoming fiscal, with the budget allocation going up to Rs. 108.55, compared to the BE stage allocation of Rs. 54.98 crore, primarily owing the high estimate of capital expenditure at Rs. 48.95 crore for FY26.
The allocation for National Medicinal Plants Board is also expected to go up to Rs. 18.59 crore in FY26, as compared to Rs. 14.63 crore in the BE stage of FY25, and Rs. 16.75 crore in the RE stage.
Under the Central Sponsored Scheme of National Ayush Mission, the transfers to the States and Union Territories is expected to be Rs. 1,275 crore during FY26, as compared to the BE of Rs. 1,200 crore and the RE of Rs. 1,046 crore in FY25.
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|